Annual CFF
-$287.81 M
-$51.00 M-21.54%
27 September 2024
Summary:
Dolby Laboratories annual cash flow from financing activities is currently -$287.81 million, with the most recent change of -$51.00 million (-21.54%) on 27 September 2024. During the last 3 years, it has fallen by -$35.30 million (-13.98%). DLB annual CFF is now -217.61% below its all-time high of $244.71 million, reached on 30 September 2005.DLB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$60.12 M
-$1.72 M-2.95%
27 September 2024
Summary:
Dolby Laboratories quarterly cash flow from financing activities is currently -$60.12 million, with the most recent change of -$1.72 million (-2.95%) on 27 September 2024. Over the past year, it has increased by +$65.02 million (+51.96%). DLB quarterly CFF is now -124.61% below its all-time high of $244.31 million, reached on 31 March 2005.DLB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$287.81 M
-$17.32 M-6.40%
27 September 2024
Summary:
Dolby Laboratories TTM cash flow from financing activities is currently -$287.81 million, with the most recent change of -$17.32 million (-6.40%) on 27 September 2024. Over the past year, it has dropped by -$15.96 million (-5.87%). DLB TTM CFF is now -214.89% below its all-time high of $250.52 million, reached on 30 December 2005.DLB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DLB Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -21.5% | +52.0% | -5.9% |
3 y3 years | -14.0% | +17.5% | -3.1% |
5 y5 years | +25.3% | -24.5% | +2.5% |
DLB Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -21.5% | +52.9% | -63.3% | +75.2% | -21.5% | +54.2% |
5 y | 5 years | -38.5% | +52.9% | -63.3% | +75.2% | -39.8% | +54.2% |
alltime | all time | -217.6% | +52.9% | -124.6% | +87.1% | -214.9% | +58.6% |
Dolby Laboratories Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | -$287.81 M(+21.5%) | -$60.12 M(+3.0%) | -$287.81 M(+6.4%) |
June 2024 | - | -$58.40 M(+32.2%) | -$270.49 M(+8.7%) |
Mar 2024 | - | -$44.16 M(-64.7%) | -$248.92 M(-8.4%) |
Dec 2023 | - | -$125.14 M(+192.4%) | -$271.86 M(+14.8%) |
Sept 2023 | -$236.81 M(-61.2%) | -$42.80 M(+16.2%) | -$236.81 M(-45.7%) |
June 2023 | - | -$36.83 M(-45.1%) | -$436.44 M(-27.0%) |
Mar 2023 | - | -$67.10 M(-25.5%) | -$597.49 M(-4.8%) |
Dec 2022 | - | -$90.09 M(-62.8%) | -$627.81 M(+2.8%) |
Sept 2022 | -$610.56 M(+141.8%) | -$242.43 M(+22.5%) | -$610.56 M(+34.2%) |
June 2022 | - | -$197.87 M(+103.1%) | -$455.00 M(+50.7%) |
Mar 2022 | - | -$97.42 M(+33.7%) | -$302.00 M(+8.2%) |
Dec 2021 | - | -$72.84 M(-16.1%) | -$279.01 M(+10.5%) |
Sept 2021 | -$252.51 M(+21.5%) | -$86.86 M(+93.5%) | -$252.51 M(+15.0%) |
June 2021 | - | -$44.88 M(-39.7%) | -$219.51 M(+3.5%) |
Mar 2021 | - | -$74.43 M(+60.6%) | -$212.06 M(+3.0%) |
Dec 2020 | - | -$46.34 M(-14.0%) | -$205.84 M(-0.9%) |
Sept 2020 | -$207.78 M(-46.1%) | -$53.86 M(+43.9%) | -$207.78 M(-4.1%) |
June 2020 | - | -$37.43 M(-45.1%) | -$216.62 M(-19.9%) |
Mar 2020 | - | -$68.21 M(+41.3%) | -$270.32 M(-8.4%) |
Dec 2019 | - | -$48.28 M(-23.0%) | -$295.13 M(-23.4%) |
Sept 2019 | -$385.28 M(+188.3%) | -$62.70 M(-31.2%) | -$385.28 M(+1.4%) |
June 2019 | - | -$91.13 M(-2.0%) | -$379.86 M(+9.4%) |
Mar 2019 | - | -$93.02 M(-32.8%) | -$347.22 M(+38.5%) |
Dec 2018 | - | -$138.43 M(+141.7%) | -$250.79 M(+87.7%) |
Sept 2018 | -$133.63 M(+25.1%) | -$57.28 M(-2.1%) | -$133.63 M(+41.8%) |
June 2018 | - | -$58.49 M(-1811.2%) | -$94.21 M(+79.4%) |
Mar 2018 | - | $3.42 M(-116.1%) | -$52.51 M(-39.0%) |
Dec 2017 | - | -$21.27 M(+19.1%) | -$86.13 M(-19.4%) |
Sept 2017 | -$106.83 M(+16.1%) | -$17.86 M(+6.4%) | -$106.83 M(+15.1%) |
June 2017 | - | -$16.79 M(-44.4%) | -$92.86 M(+38.5%) |
Mar 2017 | - | -$30.20 M(-28.1%) | -$67.06 M(-18.8%) |
Dec 2016 | - | -$41.98 M(+979.4%) | -$82.63 M(-10.2%) |
Sept 2016 | -$91.99 M(-33.6%) | -$3.89 M(-143.2%) | -$91.99 M(-42.5%) |
June 2016 | - | $9.00 M(-119.7%) | -$159.96 M(-11.2%) |
Mar 2016 | - | -$45.77 M(-10.8%) | -$180.08 M(+15.7%) |
Dec 2015 | - | -$51.33 M(-28.6%) | -$155.69 M(+12.4%) |
Sept 2015 | -$138.52 M(+241.3%) | -$71.86 M(+546.3%) | -$138.52 M(+66.8%) |
June 2015 | - | -$11.12 M(-48.0%) | -$83.06 M(-12.7%) |
Mar 2015 | - | -$21.38 M(-37.4%) | -$95.13 M(+45.2%) |
Dec 2014 | - | -$34.16 M(+108.2%) | -$65.49 M(+61.4%) |
Sept 2014 | -$40.58 M | -$16.41 M(-29.2%) | -$40.58 M(+21.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2014 | - | -$23.18 M(-380.7%) | -$33.28 M(+156.1%) |
Mar 2014 | - | $8.26 M(-189.3%) | -$13.00 M(-58.5%) |
Dec 2013 | - | -$9.25 M(+1.6%) | -$31.35 M(-93.6%) |
Sept 2013 | -$487.96 M(+91.9%) | -$9.11 M(+214.0%) | -$487.96 M(-12.4%) |
June 2013 | - | -$2.90 M(-71.3%) | -$556.98 M(-14.1%) |
Mar 2013 | - | -$10.09 M(-97.8%) | -$648.08 M(-6.9%) |
Dec 2012 | - | -$465.87 M(+496.4%) | -$695.96 M(+173.7%) |
Sept 2012 | -$254.32 M(+56.5%) | -$78.12 M(-16.9%) | -$254.32 M(+9.7%) |
June 2012 | - | -$94.00 M(+62.2%) | -$231.76 M(+18.2%) |
Mar 2012 | - | -$57.97 M(+139.3%) | -$196.09 M(+18.2%) |
Dec 2011 | - | -$24.23 M(-56.4%) | -$165.90 M(+2.1%) |
Sept 2011 | -$162.50 M(-12.1%) | -$55.56 M(-4.8%) | -$162.50 M(-2.6%) |
June 2011 | - | -$58.33 M(+110.0%) | -$166.77 M(-7.8%) |
Mar 2011 | - | -$27.77 M(+33.3%) | -$180.83 M(-11.1%) |
Dec 2010 | - | -$20.83 M(-65.2%) | -$203.46 M(+10.1%) |
Sept 2010 | -$184.77 M(-958.5%) | -$59.83 M(-17.3%) | -$184.77 M(+55.6%) |
June 2010 | - | -$72.39 M(+43.6%) | -$118.72 M(+224.6%) |
Mar 2010 | - | -$50.40 M(+2246.5%) | -$36.57 M(-328.9%) |
Dec 2009 | - | -$2.15 M(-134.5%) | $15.98 M(-25.7%) |
Sept 2009 | $21.52 M(-38.3%) | $6.22 M(-36.2%) | $21.52 M(+3.6%) |
June 2009 | - | $9.76 M(+353.6%) | $20.78 M(-1.7%) |
Mar 2009 | - | $2.15 M(-36.6%) | $21.14 M(-20.9%) |
Dec 2008 | - | $3.39 M(-38.0%) | $26.72 M(-23.4%) |
Sept 2008 | $34.90 M(+14.3%) | $5.48 M(-45.9%) | $34.90 M(+1.8%) |
June 2008 | - | $10.12 M(+30.9%) | $34.29 M(+10.5%) |
Mar 2008 | - | $7.73 M(-33.2%) | $31.02 M(+4.6%) |
Dec 2007 | - | $11.57 M(+137.7%) | $29.66 M(-2.8%) |
Sept 2007 | $30.52 M(+51.1%) | $4.87 M(-29.0%) | $30.52 M(+4.0%) |
June 2007 | - | $6.85 M(+7.5%) | $29.34 M(+8.3%) |
Mar 2007 | - | $6.37 M(-48.7%) | $27.08 M(+1.2%) |
Dec 2006 | - | $12.43 M(+237.7%) | $26.75 M(+32.4%) |
Sept 2006 | $20.20 M(-91.7%) | $3.68 M(-20.0%) | $20.20 M(+21.2%) |
June 2006 | - | $4.60 M(-23.9%) | $16.67 M(+36.0%) |
Mar 2006 | - | $6.04 M(+2.8%) | $12.26 M(-95.1%) |
Dec 2005 | - | $5.88 M(+3845.6%) | $250.52 M(+2.4%) |
Sept 2005 | $244.71 M(<-9900.0%) | $149.00 K(-19.5%) | $244.71 M(+0.1%) |
June 2005 | - | $185.00 K(-99.9%) | $244.56 M(+0.1%) |
Mar 2005 | - | $244.31 M(>+9900.0%) | $244.38 M(>+9900.0%) |
Dec 2004 | - | $74.00 K | $74.00 K |
Sept 2004 | -$20.00 K(-98.6%) | - | - |
Sept 2003 | -$1.40 M | - | - |
FAQ
- What is Dolby Laboratories annual cash flow from financing activities?
- What is the all time high annual CFF for Dolby Laboratories?
- What is Dolby Laboratories annual CFF year-on-year change?
- What is Dolby Laboratories quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dolby Laboratories?
- What is Dolby Laboratories quarterly CFF year-on-year change?
- What is Dolby Laboratories TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dolby Laboratories?
- What is Dolby Laboratories TTM CFF year-on-year change?
What is Dolby Laboratories annual cash flow from financing activities?
The current annual CFF of DLB is -$287.81 M
What is the all time high annual CFF for Dolby Laboratories?
Dolby Laboratories all-time high annual cash flow from financing activities is $244.71 M
What is Dolby Laboratories annual CFF year-on-year change?
Over the past year, DLB annual cash flow from financing activities has changed by -$51.00 M (-21.54%)
What is Dolby Laboratories quarterly cash flow from financing activities?
The current quarterly CFF of DLB is -$60.12 M
What is the all time high quarterly CFF for Dolby Laboratories?
Dolby Laboratories all-time high quarterly cash flow from financing activities is $244.31 M
What is Dolby Laboratories quarterly CFF year-on-year change?
Over the past year, DLB quarterly cash flow from financing activities has changed by +$65.02 M (+51.96%)
What is Dolby Laboratories TTM cash flow from financing activities?
The current TTM CFF of DLB is -$287.81 M
What is the all time high TTM CFF for Dolby Laboratories?
Dolby Laboratories all-time high TTM cash flow from financing activities is $250.52 M
What is Dolby Laboratories TTM CFF year-on-year change?
Over the past year, DLB TTM cash flow from financing activities has changed by -$15.96 M (-5.87%)